Thank you, Mr. Chair.
Thank you to the witnesses for coming.
I want to follow up on what Dr. Kitchen talked about.
I want to also thank you for advocating for pharmacists. One of my very good friends, my mentors, and the one whom I trust with all of my medication, is Akil Dhirani, who's running many practices. I often go to him for advice on many things, especially around pharmacare.
I'll ask you a very simple question. I believe you are familiar with the health care plan that we have. If I develop type 1 diabetes, what would be the scenario today for me? What would be the difference between today versus tomorrow, when this bill passes? What would it be when I go to Akil and say, “Akil, now I have type 1 diabetes, but insulin is universally available now. What change would I see in treatment? What change should I anticipate from my insurance provider?”